Validation of the accuracy of contact force measurement by contemporary force-sensing ablation catheters
Thomas Kueffer MSca, Andreas Haeberlin MD, PhDa,b, Sven Knecht DScc, Samuel H Baldinger MDa, Antonio Madaffari MDa, Jens Seiler MDa, Aline Mühl MSca, Hildegard Tanner MDa, Laurent Roten MDa, Tobias Reichlin MDa
a Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
b ARTORG Center for Biomedical Engineering, University of Bern, Switzerland
c Department of Cardiology, University Hospital Basel, Basel, Switzerland
Running title: Accuracy of force sensing ablation catheters
Word count: 2368

Corresponding author

Prof. Dr. med. Tobias Reichlin, MD
Department of Cardiology, Inselspital – University Hospital Bern
Freiburgstrasse, CH-3010 Bern, Switzerland Email: tobias.reichlin@insel.ch Phone: +41 (0)31 634 00 50

Conflict of interest

A. Haeberlin: Research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, the University of Bern, the University Hospital Bern, the Velux Foundation, the Hasler Foundation, the Swiss Heart Rhythm Foundation, and the Novartis Research Foundation. He is Co-founder and CEO of Act-Inno, a cardiovascular device testing company. He has received travel fees/educational grants from Medtronic, Philips/Spectranetics and Cairdac without impact on his personal remuneration.
L. Roten: speaker honoraria from Abbott/SJM and consulting honoraria from Medtronic.
T. Reichlin: Research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, and the sitem insel support funds, all for work outside the submitted study. Speaker/consulting honoraria or travel support from Abbott/SJM, Astra Zeneca, Brahms, Bayer, Biosense-Webster, Biotronik, Boston-Scientific, Daiichi Sankyo, Farapulse, Medtronic, Pfizer-BMS and Roche, all for work outside the submitted study. Support for his institution’s fellowship program from Abbott/SJM, Biosense-Webster, Biotronik, Boston-Scientific and Medtronic for work outside the submitted study.
J. Seiler: The spouse of Dr Seiler is an employee and stock owner of Boston Scientific.
F. Noti: Medtronic, Abbott: Travel fees, speaker fees, educational grant; Boston Scientific, Philips Spectranetics: Travel fees, educational grant; Biotronik: Institutional grant all for work outside the submitted study.
All other authors report no conflicts of interest related to this paper.